Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
← catalyst calendarSponsored by Materialise (industry) · MTLS.BR — their whole pipeline →.
Phase
—
Status
Enrolling by invitation
Study type
Observational
Enrollment
24estimated
Sites
4
Countries
Belgium, Netherlands
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2019-07-01 | actual | When the study began enrolling |
| Primary completion | 2024-10-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-12-01 | estimated | The whole study's end, after follow-up |
| First posted | 2019-01-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-03-13 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Arthroplasty, Replacement, Shoulder
- Glenoid Cavity
- Osteoarthritis of the Shoulder
Intervention
- Device: reversed glenoid prothesis — also filed as Glenius Glenoid Reconstruction system
Primary outcome
what the primary-completion date above is the date OFChange in baseline Constant-Murley Score after surgery
measured 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery
Permalink · MTLS.BR's whole pipeline · Catalyst calendar · Every registered study · What changed